As Pitt innovators continue to set new records for the amount of innovation coming from their classrooms and labs, the University has stepped up its support for translating those ideas and discoveries into products and services that can make a difference in peoples’ lives.
Transcriptional Therapy Startup Seeks to Coax Failing Liver Cells Back to Health
The road to taking university research from the lab and translating it into a therapy approved by the Food and Drug Administration is long and perilous. Fiscal 2020 marked significant progress for companies that have licensed Pitt technologies in the therapeutics space in advancing from the pre-clinical development stage to FDA approved clinical trials.
Industry partnerships provide an important channel for the translation of research to societal impact. In FY 2020, Pitt faculty partnered with 375 different companies on research projects totaling more than $40 million. From basic research to clinical trials, Pitt innovators are building new partnerships every day that help advance their research goals.